ConductScience.org, home

Paper280391

A physiological basis for the treatment of essential hypertension.

Weber MA and 1 other. Bull N Y Acad Med, 1978. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. A physiological basis for the treatment of essential hypertension. Papers, record 280391. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/280391

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A physiological basis for the treatment of essential hypertension.
PubMed
Journal
Bull N Y Acad Med
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Weber MAM A
2Laragh JHJ H

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
Aldosterone
Clonidine
Diuretics
Humans
Propranolol
Renin
Sodium

Source PubMed

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1190,537Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme.N Engl J Med1977https://conductscience.org/library/papers/190537PubMed
2190,882Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity.Am J Med1976https://conductscience.org/library/papers/190882PubMed
31,020,762Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.Am J Med1976https://conductscience.org/library/papers/1020762PubMed
41,020,761Angiotensin blockade: its clinical significance.Am J Med1976https://conductscience.org/library/papers/1020761PubMed
5998,518Renin and aldosterone suppression in the antihypertensive action of clonidine.Am J Cardiol1976https://conductscience.org/library/papers/998518PubMed
6980,059Reciprocal relation between renin dependency and sodium dependency in essential hypertension.N Engl J Med1976https://conductscience.org/library/papers/980059PubMed
74,257,928Essential hypertension: renin and aldosterone, heart attack and stroke.N Engl J Med1972https://conductscience.org/library/papers/4257928PubMed
84,355,699Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.Am J Med1973https://conductscience.org/library/papers/4355699PubMed
94,597,950Vasodilator drugs in the treatment of hypertension.Arch Intern Med1974https://conductscience.org/library/papers/4597950PubMed
104,726,158Side effects of hypotensive agents evaluated by a self-administered questionnaire.Br Med J1973https://conductscience.org/library/papers/4726158PubMed
114,729,722Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.Am J Cardiol1973https://conductscience.org/library/papers/4729722PubMed
124,729,721Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.Am J Cardiol1973https://conductscience.org/library/papers/4729721PubMed
135,082,464The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.Arch Intern Med1972https://conductscience.org/library/papers/5082464PubMed
145,084,985Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.N Engl J Med1972https://conductscience.org/library/papers/5084985PubMed
155,017,240Hyporeninemic hypertension.Am J Med1972https://conductscience.org/library/papers/5017240PubMed
164,914,579Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg.JAMA1970https://conductscience.org/library/papers/4914579PubMed
175,599,096The meaning of aldosteronism in hypertensive disease.Circ Res1967https://conductscience.org/library/papers/5599096PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/280391

GET https://conductscience.org/api/papers/v1/280391/authors